NOX 4.17% 6.9¢ noxopharm limited

Ann: New Independent Trial Data Supports Potential of Veyonda, page-21

  1. 920 Posts.
    lightbulb Created with Sketch. 129
    Sounding very ignorant indeed...
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.